http://www.onemedplace.com/blog/wp-content/uploads/2009/09/autism.jpg
Seaside Therapeutics has secured $30 million in funding from a private, unnamed family investment firm committed to finding treatments for autism and Fragile X syndrome.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/07/children-hands.jpg
Seaside Therapeutics reported encouraging results from the largest randomized study conducted to date in patients with Fragile X syndrome.
View Article
More Pages to Explore .....
